ZA931100B - A 90K tumor-associated antigen, IR-95. - Google Patents

A 90K tumor-associated antigen, IR-95.

Info

Publication number
ZA931100B
ZA931100B ZA931100A ZA931100A ZA931100B ZA 931100 B ZA931100 B ZA 931100B ZA 931100 A ZA931100 A ZA 931100A ZA 931100 A ZA931100 A ZA 931100A ZA 931100 B ZA931100 B ZA 931100B
Authority
ZA
South Africa
Prior art keywords
tumor
associated antigen
antigen
Prior art date
Application number
ZA931100A
Other languages
English (en)
Inventor
Stefano Lacobelli
Clara Natoli
Joseph Schlessinger
Original Assignee
Univ New York
Iversita Degli Studi G D Annun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York, Iversita Degli Studi G D Annun filed Critical Univ New York
Publication of ZA931100B publication Critical patent/ZA931100B/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015Breast
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA931100A 1992-02-17 1993-02-17 A 90K tumor-associated antigen, IR-95. ZA931100B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920099A IT1264490B (it) 1992-02-17 1992-02-17 Antigene 90k associato a tumori.

Publications (1)

Publication Number Publication Date
ZA931100B true ZA931100B (en) 1994-08-17

Family

ID=11400690

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931100A ZA931100B (en) 1992-02-17 1993-02-17 A 90K tumor-associated antigen, IR-95.

Country Status (6)

Country Link
CN (1) CN1076629A (xx)
AU (2) AU3629093A (xx)
IL (1) IL104745A0 (xx)
IT (1) IT1264490B (xx)
WO (2) WO1993017119A2 (xx)
ZA (1) ZA931100B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2175922A1 (en) * 1993-11-05 1995-05-11 Stefano Iacobelli Methods relating to ir-95
CN1313603C (zh) * 2004-09-30 2007-05-02 北京大学人民医院 抗人卵巢癌单克隆抗体杂交瘤细胞系及其单克隆抗体和应用
GB2435882A (en) * 2006-03-09 2007-09-12 Bioinvent Int Ab Detection and treatment of mantle cell lymphoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies
IT1239719B (it) * 1990-04-23 1993-11-15 Univ Degli Studi Annunzio Uso dell'anticorpo monoclonale sp-2 nella diagnostica clinica ed il monitoraggio del progredire dell'infezione hiv

Also Published As

Publication number Publication date
AU3629093A (en) 1993-09-13
WO1993016181A1 (en) 1993-08-19
CN1076629A (zh) 1993-09-29
ITRM920099A1 (it) 1993-08-18
AU3497993A (en) 1993-09-03
IL104745A0 (en) 1993-06-10
WO1993017119A2 (en) 1993-09-02
IT1264490B (it) 1996-09-24
ITRM920099A0 (it) 1992-02-17

Similar Documents

Publication Publication Date Title
EP0627932A4 (en) NEW ANTIBODY STRUCTURE.
EP0656628A3 (en) Programmed reference.
AR244082A1 (es) Composiciones de champu
EP0580285A3 (en) Auto-reclosers.
ZA939450B (en) A comb.
EP0703659A4 (en) AC POWERED ELECTRODYNAMIC DEVICE WITH SEVERAL ROTORS
ZA926733B (en) 1,2-Dihydro-2-oxopyridines.
EP0676966A4 (en) Antibodies directed against binding associated epitopes.
ZA931232B (en) A joining device.
EP0640758A3 (en) Charge dosing device.
EP0649734A3 (en) Packaging.
EP0640757A3 (en) Load metering device.
EP0652630A3 (en) Semiconductor stack.
EP0644636A3 (en) Wavelength conversion device.
GB2272220B (en) a,w-alkanediphenols
EP0609522A3 (de) Verpackung.
ZA937127B (en) Catch.
AU3497893A (en) Sequences for a 90K tumor-associated antigen, immunoregulin-95 (IR-95)
EP0603840A3 (de) Schwenklager.
EP0571983A3 (en) Macromonomeric compounds terminated in alpha, omega with methacrylate.
ZA931100B (en) A 90K tumor-associated antigen, IR-95.
EP0671665A3 (en) Sorter.
EP0634841A3 (en) Smooth spectrum spread with a small spreading factor.
EP0624089A4 (en) Methods.
ZA93432B (en) Improved packaging element.